|
| Drug repurposing using highthroughput screening identifies a promising drug combination to treat adrenocortical carcinoma |
|
https://doi.org/10.18632/oncotarget.26091
Antonio M. Lerario, and Gary D. Hammer
|
| 33245-33246 |
|
| The role of p16 as a biomarker in nonoropharyngeal head and neck cancer |
|
https://doi.org/10.18632/oncotarget.26053
Lucas K. Vitzthum, and Loren K. Mell
|
| 33247-33248 |
|
| Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer |
|
https://doi.org/10.18632/oncotarget.26064
Tazeem Shaik, Gulam M, Rather, Nitu Bansal, Tamara Minko, Olga Garbuzenko, Zoltan Szekely, Emine E. Abali, Debabrata Banerjee, John E. Kerrigan, Kathleen W. Scotto, and Joseph R. Bertino
|
| 33249-33257 |
|
| Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25947
Yudong Wang, Zhijie Wang, Sarina Piha-Paul, Filip Janku, Vivek Subbiah, Naiyi Shi, Kenneth Hess, Russell Broaddus, Baoen Shan, Aung Naing, David Hong, Apostolia M. Tsimberidou, Daniel Karp, Charles Lu, Vali Papadimitrakopoulou, John Heymach, Funda Meric-Bernstam, and Siqing Fu
|
| 33258-33270 |
|
| Glioblastoma in the setting of prior lower grade gliomas – insights from SEER database |
|
https://doi.org/10.18632/oncotarget.26014
Ha Son Nguyen, Benjamin Best, Ninh B. Doan, Michael Gelsomino, Saman Shabani, Ahmed J. Awad, Mayank Kaushal, and Martin M. Mortazavi
|
| 33271-33277 |
|
| Metabolite quantification of faecal extracts from colorectal cancer patients and healthy controls |
|
https://doi.org/10.18632/oncotarget.26022
Gwénaëlle Le Gall, Kiran Guttula, Lee Kellingray, Adrian J. Tett, Rogier ten Hoopen, E. Kate Kemsley, George M. Savva, Ashraf Ibrahim, and Arjan Narbad
|
| 33278-33289 |
|
| Singlecell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel |
|
https://doi.org/10.18632/oncotarget.26044
Shengwen Calvin Li, Andres Stucky, Xuelian Chen, Mustafa H. Kabeer, William G. Loudon, Ashley S. Plant, Lilibeth Torno, Chaitali S. Nangia, Jin Cai, Gang Zhang, and Jiang F. Zhong
|
| 33290-33301 |
|
| The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7 |
|
https://doi.org/10.18632/oncotarget.26048
Dominique Thuringer, Gaetan Chanteloup, Pascale Winckler, and Carmen Garrido
|
| 33302-33311 |
|
| Role of textural heterogeneity parameters in patient selection for 177LuPSMA therapy via response prediction |
|
https://doi.org/10.18632/oncotarget.26051
Zain Khurshid, Hojjat Ahmadzadehfar, Florian C. Gaertner, László Papp, Norbert Zsóter, Markus Essler, and Ralph A. Bundschuh
|
| 33312-33321 |
|
| A safety study of newly generated antipodoplaninneutralizing antibody in cynomolgus monkey Macaca fascicularis |
|
https://doi.org/10.18632/oncotarget.26055
Takao Ukaji, Ai Takemoto, Ryohei Katayama, Kengo Takeuchi, and Naoya Fujita
|
| 33322-33336 |
|
| Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer |
|
https://doi.org/10.18632/oncotarget.26071
Chie Kikutake, Minako Yoshihara, Tetsuya Sato, Daisuke Saito, and Mikita Suyama
|
| 33337-33347 |
|
| Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triplenegative breast cancer subtype by transcriptome profiling |
|
https://doi.org/10.18632/oncotarget.26072
Khalid N. Al-Zahrani, David P. Cook, Barbara C. Vanderhyden, and Luc A. Sabourin
|
| 33348-33359 |
|
| Loss of Gadd45b accelerates BCRABLdriven CML |
|
https://doi.org/10.18632/oncotarget.26076
Xiaojin Sha, Barbara Hoffman, and Dan A. Liebermann
|
| 33360-33367 |
|
| N2´Hydroxyphenyl2propylpentanamide OHVPA a histone deacetylase inhibitor induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells |
|
https://doi.org/10.18632/oncotarget.26077
Arturo Contis-Montes de Oca, EstefanÃa Rodarte-Valle, Martha Cecilia Rosales-Hernández, Edgar Abarca-Rojano, Saúl Rojas-Hernández, Manuel Jonathan Fragoso-Vázquez, Jessica Elena Mendieta-Wejebe, Ana MarÃa Correa-Basurto, Ismael Vázquez-Moctezuma, and José Correa-Basurto
|
| 33368-33381 |
|
| Genetic disruption of calpain1 and calpain2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib |
|
https://doi.org/10.18632/oncotarget.26078
James A. MacLeod, Yan Gao, Christine Hall, William J. Muller, Taranjit S. Gujral, and Peter A. Greer
|
| 33382-33395 |
|
| Metaanalysis of the likelihood of FOXC2 expression in early and latestage tumors |
|
https://doi.org/10.18632/oncotarget.26087
Tsutomu Kume, and Tarek Shackour
|
| 33396-33402 |
|
| Cancer stem cells in progression of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.23607
Yujuan Zhou, Longzheng Xia, Heran Wang, Linda Oyang, Min Su, Qiang Liu, Jingguan Lin, Shiming Tan, Yutong Tian, Qianjin Liao, and Deliang Cao
|
| 33403-33415 |
|
| Inhibition of interleukin1 receptorassociated kinase 1 IRAK1 as a therapeutic strategy |
|
https://doi.org/10.18632/oncotarget.26058
Jack W. Singer, Angela Fleischman, Suliman Al-Fayoumi, John O. Mascarenhas, Qiang Yu, and Anupriya Agarwal
|
| 33416-33439 |
|
| Correction: Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer |
|
https://doi.org/10.18632/oncotarget.26113
Karina Brüstle, and Bettina Heidecker
|
| 33440-33440 |
|
| Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel |
|
https://doi.org/10.18632/oncotarget.26114
J. Tyson McDonald, Athena Kritharis, Afshin Beheshti, Monika Pilichowska, Kristine Burgess, Luisel Ricks-Santi, Elizabeth McNiel, Cheryl A. London, Dashnamoorthy Ravi, and Andrew M. Evens
|
| 33441-33441 |
